Frank Litvack - 13 May 2026 Form 4 Insider Report for CAPRICOR THERAPEUTICS, INC. (CAPR)

Reporting relationship: Director
Issuer ticker: CAPR
Reported as of: 13 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 May 2026, 17:00:05 UTC
Prior SEC filing: 07 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Linda Marban, Attorney-in-Fact

Key filing fact

Frank Litvack filed Form 4 for CAPRICOR THERAPEUTICS, INC. (CAPR) on 14 May 2026.

Key facts

This page summarizes Frank Litvack's Form 4 filing for CAPRICOR THERAPEUTICS, INC. (CAPR).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 14 May 2026, 17:00.

Change

Previous filing in this sequence was filed on 07 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001310715 Primary reporting owner

Litvack Frank

Relationship: Director
Address: C/O CAPRICOR THERAPEUTICS, INC., 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO
Signature: /s/ Linda Marban, Attorney-in-Fact
Signature date: 14 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAPR transaction

Common Stock

Options Exercise

Transaction value
Shares: +3,937
Change %: +3%
Price: $1.39^*
Shares after: 133,776
Date: 13 May 2026
Ownership: Direct

CAPR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 46,278
Date: 13 May 2026
Ownership: Held in Family Trust
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CAPR transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -3,937
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 13 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,937
Exercise price: $1.39
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Held by Litvack Curtis Family Trust for which the Reporting Person serves as trustee.

Footnote F2

This option was granted on June 2, 2016 and was previously reported as covering 39,375 shares at an exercise price of $3.12 per share, but was adjusted to reflect a 1-for-10 reverse stock split that occurred on June 4, 2019 and a share reprice of $1.39 per share that occurred on February 12, 2020.

Footnote F3

1,750 shares vested immediately on June 2, 2016. The remaining shares vested on December 31, 2016.